Tutogen receives delisting notice from Amex

By Elaine Rigoli

Tampa, Fla., June 2 - Tutogen Medical, Inc. announced Friday that due to its previously reported late filing of the company's 2006 second fiscal quarter quarterly report with the Securities and Exchange Commission, the company has received a possible delisting notice from the American Stock Exchange.

Tutogen said it may be subject to delisting proceedings if it fails to be in compliance with SEC filing guidelines by July 6.

As previously reported, management believes that it will have completed its restated financial statements for the 2003, 2004 and 2005 fiscal years and the 2006 first fiscal quarter during June 2006.

Tutogen manufactures sterile biological implant products made from human (allograft) and animal (xenograft) tissue and is based in Alachua, Fla.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.